Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Selective and multitargeted B-Raf inhibitors described at Deciphera

Nov. 27, 2007

Bristol-Myers Squibb and Pierre Fabre terminate license agreement for vinflunine

Nov. 26, 2007

FDA approves Bionomics' IND application for anticancer compound BNC-105

Nov. 26, 2007

Recent patents divulge new therapeutic agents for cancer

Nov. 26, 2007

Hana initiates phase II clinical trial of Marqibo for metastatic malignant uveal melanoma

Nov. 23, 2007

Merck & Co. suspends enrollment in clinical trials of kinase inhibitor MK-0457

Nov. 23, 2007

Antisoma provides update on clinical development of its anticancer compounds

Nov. 22, 2007

Preclinical profile of novel oncolytic measles virus

Nov. 22, 2007

FDA approves supplemental NDA for Nexavar for unresectable hepatocellular carcinoma

Nov. 20, 2007

Thallion reports positive safety and efficacy data from phase I/II trial of ECO-4601

Nov. 20, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...